Breast cancer: evolution of the epidemiological and clinical profile in a referral oncology center in Paraná
DOI:
https://doi.org/10.29289/2594539420250045Keywords:
breast cancer, clinical epidemiology, women’s healthAbstract
Introduction: Breast cancer is the most common malignant neoplasm among women worldwide, and disparities in staging at diagnosis between public and private healthcare systems represent a critical challenge in Brazil. This study aimed to assess the epidemiological and clinical profile of patients diagnosed with breast cancer between 2003 and 2023 at the Instituto Sul Paranaense de Oncologia in Ponta Grossa, Paraná. Methods: Data were collected from electronic medical records using a semi-structured spreadsheet, followed by statistical analysis using R software. Results: During the study period, 3,118 patients were diagnosed with breast cancer at this institution. The mean age at diagnosis was 56.23 years, with slight variations throughout the analyzed period; the most affected age group was 50 to 64 years (39.32%). Regarding histological type, the most prevalent was invasive ductal carcinoma (81.22%), followed by ductal carcinoma in situ (7.51%) and lobular carcinoma (7.32%). A statistically significant difference was observed in clinical stages at diagnosis between patients treated in the public and private systems, showing that, in advanced stages, such as clinical stage III, 34.91% of patients in the Unified Health System (SUS) were diagnosed at this stage, compared to only 18.66% in the private system. Conclusions: The epidemiological profile of the patients was consistent with that described in the literature, and no proportional increase was observed in cases among patients in younger age groups, under 40 years of age. A significant difference was identified in clinical stages at diagnosis between the public and private systems, corroborating previous findings that indicate patients in the public system are frequently diagnosed at more advanced stages, resulting in more unfavorable clinical outcomes.
Downloads
References
1. World Health Organization. Cancer [Internet]. Geneva: WHO; 2022 [cited on 2024 Mar 14]. Available from: https://www.who.int/news-room/fact-sheets/detail/cancer
2. Sung H, Ferlay J, Siegel RL, Laversanne M Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49. https://doi.org/10.3322/caac.21660
3. Instituto Nacional de Câncer José Alencar Gomes da Silva. Estimativa 2023: incidência de câncer no Brasil [Internet]. Rio de Janeiro: INCA; 2022 [cited on 2024 Mar 15]. Available from: https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//estimativa-2023.pdf
4. Heidary Z, Ghaemi M, Rashidi BH, Gargari OK, Montazeri A. Quality of life in breast cancer patients: a systematic review of the qualitative studies. Cancer Control. 2023;30:10732748231168318. https://doi.org/10.1177/10732748231168318
5. Lôbo SA, Fernandes AFC, Almeida PC, Carvalho CML, Sawada NO. Qualidade de vida em mulheres com neoplasias de mama em quimioterapia. Acta Paul Enferm. 2014;27(6):554-9. https://doi.org/10.1590/1982-0194201400090
6. Brewer HR, Jones ME, Schoemaker MJ, Ashworth A, Swerdlow AJ. Family history and risk of breast cancer: an analysis accounting for family structure. Breast Cancer Res Treat. 2017;165(1):193-200. https://doi.org/10.1007/s10549-017-4325-2
7. Picon-Ruiz M, Morata-Tarifa C, Valle-Goffin JJ, Friedman ER, Slingerland JM. Obesity and adverse breast cancer risk and outcome: mechanistic insights and strategies for intervention. CA Cancer J Clin. 2017;67(5):378-97. https://doi.org/10.3322/caac.21405
8. Łukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanislawek A. Breast cancer-epidemiology, risk factors, classification, prognostic markers, and current treatment strategies-an updated review. Cancers (Basel). 2021;13(17):4287. https://doi.org/10.3390/cancers13174287
9. Obeagu EI, Obeagu, GU. Breast cancer: a review of risk factors and diagnosis. Medicine (Baltimore). 2024;103(3):e36905. https://doi.org/10.1097/MD.0000000000036905
10. Tsunoda AT, Nunes JS, Watanabe APHU, Santos-Junior LA, Maudad EC, Brentani RR. Controle de qualidade em ratreamento mamográfico no Brasil: experiência do Hospital de Câncer de Barretos. Rev Bras Mastologia. 2013;23(1):12-8.
11. Vieira RAC, Formenton A, Bertolini SR. Breast cancer screening in Brazil. Barriers related to the health system. Rev Assoc Med Bras (1992). 2017;63(5):466-74. https://doi.org/10.1590/1806- 9282.63.05.466
12. Rosa DD, Bines J, Werutsky G, Barrios CH, Cronemberger E, Queiroz GS, et al. The impact of sociodemographic factors and health insurance coverage in the diagnosis and clinicopathological characteristics of breast cancer in Brazil: AMAZONA III study (GBECAM 0115). Breast Cancer Res Treat. 2020;183(3):749-57. https://doi.org/10.1007/s10549-020-05831-y
13. R Core Team. R: A Language and environment for statistical computing. [Internet]. Vienna: R Foundation for Statistical Computing; 2024 [cited on 2025 Jun 12]. Available from: https://www.R-project.org/
14. National Cancer Institute. Division of Cancer Control & Population Sciences. Surceillance Research Program. Joinpoint trend analysis software [Internet]. National Cancer Institute; 2023 [cited on 2026 Mar 20]. Available from: https://surveillance.cancer.gov/joinpoint/
15. Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12-49. https://doi.org/10.3322/caac.21820
16. Giaquinto AN, Sung H, Miller KD, Kramer JL, Newman LA, Minihan A, et al. Breast cancer statistics, 2022. CA Cancer J Clin. 2022;72(6):524-41. https://doi.org/10.3322/caac.21754
17. Cardoso R, Ola I, Jansen L, Hackl M, Ihle P, Francart J, et al. Breast cancer incidence, by stage at diagnosis, and mortality in 21 European countries in the era of mammography screening: an international population-based study. Lancet Reg Health Eur. 2026;62:101574. https://doi.org/10.1016/j.lanepe.2025.101574
18. Dybal V, Santana G, Marques J, Barbosa L, Bezerril B, Gurgel C. Mammographic screening in the Brazilian Unified Health System. JCO Glob Oncol. 2026;12:e2500426. https://doi.org/10.1200/GO-25-00426
19. Medeiros JM, Linhares JC, Hatschbach SBB, Hubie DP, Ribeiro R, Rahman SA, et al. Perfil epidemiológico e estudo de sobrevida dos pacientes com câncer de mama atendidos no Hospital Erasto Gaertner em Curitiba, PR. Rev Bras Mastologia. 2016;26(3):107-12. https://doi.org/10.5327/Z201600030005RBM
20. Oliveira NPD, Cancela MC, Martins LFL, Souza DLB. Spatial distribution of advanced stage diagnosis and mortality of breast cancer: socioeconomic and health service offer inequalities in Brazil. PLoS One. 2021;16(2):e0246333. https://doi.org/10.1371/journal.pone.0246333
21. Andrade DAP, Veneziani AC, Paiva CE, Reis R, Fruet Filho CA, Sanches AON, et al. Discrepancies in breast cancer’s oncological outcomes between public and private institutions in the southeast region of Brazil: a retrospective cohort study. Front Oncol. 2023;13:1169982. https://doi.org/10.3389/fonc.2023.1169982
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Gabriel Wesley Barbosa dos Santos, Luiz Roberto Cavassola Ribas, Fabio Postiglione Mansani

This work is licensed under a Creative Commons Attribution 4.0 International License.




